Globe Biomedical

Globe Biomedical is a medical device and digital health company founded in 2017, headquartered in Riverside, California. The company develops wearable biosensing platforms embedded in consumer form factors, with a focus on the oculomics space—the measurement and analysis of physiological signals detectable through ocular metrics. Their lead commercial product, Blink® Frames, is a smart eyeglass system that passively captures intraocular pressure (IOP), blink dynamics, tear film stability, and environmental data, streaming metrics to a cloud platform for analysis. The Blink system integrates three core competencies: proprietary microsensing hardware for low-power, high-fidelity physiological capture; neural analytics software utilizing proprietary DINA algorithms to extract actionable health signals from environmental and behavioral data; and mechanical system integration to embed medical-grade sensors into fashion-forward consumer eyewear. The platform targets the myopia epidemic and broader ophthalmic biomarker discovery. Globe Biomedical holds multiple patents and is actively engaging clinical research partners and hardware fabrication collaborators. Their technology stack spans silicon design through cloud-based data analytics, positioning them at the intersection of consumer wearables, clinical diagnostics, and digital health intelligence.